Sera Prognostics, Inc. (SERA)
NASDAQ: SERA · Real-Time Price · USD
2.290
+0.045 (2.00%)
At close: Jun 5, 2026, 4:00 PM EDT
2.210
-0.080 (-3.49%)
After-hours: Jun 5, 2026, 7:11 PM EDT
Sera Prognostics Market Cap
Sera Prognostics has a market cap or net worth of $89.67 million as of June 5, 2026. Its market cap has increased by 23.98% in one year.
Market Cap
89.67M
Enterprise Value
5.41M
1-Year Change
23.98%
Ranking
Category
Stock Price
$2.29
Market Cap Chart
Since the IPO on July 15, 2021, Sera Prognostics's market cap has decreased from $488.14M to $89.67M, a decrease of -81.63%. That is a compound annual growth rate of -29.27%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 5, 2026 | 89.67M | -21.24% |
| Dec 31, 2025 | 113.85M | -58.58% |
| Dec 31, 2024 | 274.91M | 46.70% |
| Dec 29, 2023 | 187.39M | 379.49% |
| Dec 30, 2022 | 39.08M | -81.47% |
| Dec 31, 2021 | 210.90M | -56.79% |
| Jul 15, 2021 | 488.14M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AVITA Medical | 128.65M |
| SANUWAVE Health | 126.92M |
| MaxCyte | 122.12M |
| Rapid Micro Biosystems | 98.35M |
| Neuronetics | 89.77M |
| Outset Medical | 84.90M |
| electroCore | 72.34M |
| LENSAR | 67.78M |